FR2111947A1 - - Google Patents

Info

Publication number
FR2111947A1
FR2111947A1 FR7138778A FR7138778A FR2111947A1 FR 2111947 A1 FR2111947 A1 FR 2111947A1 FR 7138778 A FR7138778 A FR 7138778A FR 7138778 A FR7138778 A FR 7138778A FR 2111947 A1 FR2111947 A1 FR 2111947A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7138778A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of FR2111947A1 publication Critical patent/FR2111947A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06173—Dipeptides with the first amino acid being heterocyclic and Glp-amino acid; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7138778A 1970-10-30 1971-10-28 Withdrawn FR2111947A1 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8571370A 1970-10-30 1970-10-30

Publications (1)

Publication Number Publication Date
FR2111947A1 true FR2111947A1 (xx) 1972-06-09

Family

ID=22193467

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7138778A Withdrawn FR2111947A1 (xx) 1970-10-30 1971-10-28

Country Status (10)

Country Link
AU (1) AU3486971A (xx)
BE (1) BE774683A (xx)
BR (1) BR7107234D0 (xx)
DE (1) DE2153813A1 (xx)
FR (1) FR2111947A1 (xx)
GB (1) GB1364505A (xx)
IL (1) IL38002A0 (xx)
NL (1) NL7114701A (xx)
RO (1) RO68988A (xx)
ZA (1) ZA716958B (xx)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011068770A1 (en) * 2009-12-02 2011-06-09 Dow Global Technologies Inc. Two atom bridged dicarbonate compounds as internal donors in catalysts for polypropylene manufacture
US9045570B2 (en) 2008-12-31 2015-06-02 W.R. Grace & Co. - Conn. Procatalyst composition with substituted 1,2-phenylene aromatic diester internal donor and method
US9464144B2 (en) 2008-12-31 2016-10-11 W. R. Grace & Co.—Conn. Enhanced procatalyst composition and process

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5607969A (en) * 1992-12-24 1997-03-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem L-DOPA ethyl ester to treat Parkinson's disease
US5354885A (en) * 1992-12-24 1994-10-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Process for preparing ethyl ester of L-DOPA
AU764844B2 (en) 1998-11-10 2003-09-04 Teva Pharmaceutical Industries Ltd. Process for manufacture of L-DOPA ethyl ester
JP2002529407A (ja) 1998-11-10 2002-09-10 テバ ファーマシューティカル インダストリーズ リミティド Ｌ−ｄｏｐａエチルエステル含有分散性組成物
AU2002340470A1 (en) 2001-11-13 2003-05-26 Teva Pharmaceutical Industries, Ltd. L-dopa ethyl ester salts and uses thereof
WO2011068775A1 (en) 2009-12-02 2011-06-09 Dow Global Technologies Inc. Three and four atom bridged dicarbonate compounds as internal donors in catalysts for polypropylene manufacture
CA3212170A1 (en) * 2013-03-15 2014-09-18 Techfields Pharma Co., Ltd. Novel high penetration drugs and their compositions thereof for treatment of parkinson diseases
WO2014191997A1 (en) * 2013-05-28 2014-12-04 Ramot At Tel-Aviv University Ltd. Self-assembled micro- and nano-structures
WO2023175623A1 (en) * 2022-03-18 2023-09-21 Neuroderm, Ltd. Levodopa tyrosine polymorphs

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9045570B2 (en) 2008-12-31 2015-06-02 W.R. Grace & Co. - Conn. Procatalyst composition with substituted 1,2-phenylene aromatic diester internal donor and method
US9464144B2 (en) 2008-12-31 2016-10-11 W. R. Grace & Co.—Conn. Enhanced procatalyst composition and process
US9534063B2 (en) 2008-12-31 2017-01-03 W. R. Grace & Co.—Conn Procatalyst composition with substituted 1,2-phenylene aromatic diester internal donor and method
WO2011068770A1 (en) * 2009-12-02 2011-06-09 Dow Global Technologies Inc. Two atom bridged dicarbonate compounds as internal donors in catalysts for polypropylene manufacture

Also Published As

Publication number Publication date
IL38002A0 (en) 1971-12-29
DE2153813A1 (de) 1972-05-10
NL7114701A (xx) 1972-05-03
AU3486971A (en) 1973-05-03
RO68988A (ro) 1980-03-15
BR7107234D0 (pt) 1973-08-16
BE774683A (fr) 1972-05-02
ZA716958B (en) 1973-01-31
GB1364505A (en) 1974-08-21

Similar Documents

Publication Publication Date Title
FR2111947A1 (xx)
ATA96471A (xx)
AU1146470A (xx)
AU2044470A (xx)
AU1326870A (xx)
AU2130570A (xx)
AU2085370A (xx)
AU2017870A (xx)
AU1833270A (xx)
AU1716970A (xx)
AU1517670A (xx)
AU1336970A (xx)
AU1591370A (xx)
AU1064870A (xx)
AU2144270A (xx)
AU2131570A (xx)
AU2130770A (xx)
AU1328670A (xx)
AU1277070A (xx)
AU1343870A (xx)
AU1247570A (xx)
ATA672271A (xx)
AU2119370A (xx)
AU1581370A (xx)
AU1235770A (xx)

Legal Events

Date Code Title Description
ST Notification of lapse